US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist

0.690
-0.010-1.40%

Close Apr 26 16:00 ET

0.710
+0.020+2.90%

Post 18:51 ET

82.36MMarket Cap-264P/E (TTM)

Atara Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

28.64%-192.98M

11.38%-50.41M

21.08%-51.35M

17.46%-52.8M

54.54%-38.43M

-22.63%-270.43M

-65.98%-56.88M

-10.31%-65.06M

-3.88%-63.96M

-28.66%-84.53M

Net income from continuing operations

-20.95%-276.13M

18.94%-60.45M

17.00%-69.8M

-485.08%-71.11M

15.13%-74.77M

32.88%-228.3M

20.11%-74.57M

0.68%-84.09M

122.04%18.47M

-12.47%-88.11M

Operating gains losses

----

---50.24M

--0

----

Depreciation and amortization

-14.58%4.83M

-3.98%1.21M

-11.69%1.21M

-16.48%1.2M

-23.70%1.21M

-39.51%5.65M

-49.56%1.26M

-40.91%1.37M

-37.96%1.44M

-28.40%1.59M

Other non cash items

85.40%16.8M

41.12%4.08M

56.60%4.34M

52.51%4.22M

556.62%4.16M

340.76%9.06M

302.93%2.89M

412.38%2.77M

584.90%2.77M

60.91%634K

Change In working capital

124.96%15.34M

-440.84%-7.28M

178.93%1.97M

102.15%1.09M

245.02%19.55M

-216.89%-61.47M

-94.83%2.14M

-91.84%707K

-1,078.21%-50.83M

-417.15%-13.48M

-Change in receivables

115.58%6.11M

15.08%-33.95M

-11.34%344K

-454.84%-110K

12,423.27%39.82M

-14,961.74%-39.24M

-3,953.96%-39.97M

--388K

-99.68%31K

103.80%318K

-Change in inventory

-411.98%-8.12M

-96.41%-3.12M

--1.27M

---2.52M

---3.75M

---1.59M

--0

-Change in prepaid assets

----

227.75%2.75M

-524.30%-2.58M

----

-464.64%-2.16M

-66.68%609K

-Change in payables and accrued expense

-391.55%-6.79M

-303.89%-5.45M

5.83%10.8M

-38.99%-9.03M

23.14%-3.11M

-65.25%2.33M

-30.28%2.67M

600.07%10.2M

-117.70%-6.49M

-192.09%-4.05M

-Change in other current assets

-16.18%1.32M

-90.82%515K

122.12%911K

84.00%46K

-405.88%-156K

-75.68%1.57M

-12.69%5.61M

-45,855.56%-4.12M

225.00%25K

34.21%51K

-Change in other current liabilities

74.41%-1.43M

267.33%7.77M

-2,632.20%-5.98M

2,816.39%1.66M

-337.33%-4.89M

-645.07%-5.59M

-206.46%-4.65M

-28.70%236K

90.88%-61K

-201.18%-1.12M

-Change in other working capital

227.93%24.26M

-32.73%26.94M

31.04%-5.2M

119.67%8.3M

37.80%-5.78M

-147.50%-18.96M

-9.81%40.05M

-385.83%-7.55M

-3,063.84%-42.17M

-475.84%-9.29M

Cash from discontinued investing activities

Operating cash flow

28.64%-192.98M

11.38%-50.41M

21.08%-51.35M

17.46%-52.8M

54.54%-38.43M

-22.63%-270.43M

-65.98%-56.88M

-10.31%-65.06M

-3.88%-63.96M

-28.66%-84.53M

Investing cash flow

Cash flow from continuing investing activities

-38.97%123.87M

-80.58%9.94M

18.01%70.45M

55.48%49.48M

-109.98%-6.01M

811.83%202.96M

310.57%51.22M

4,899.75%59.7M

-0.20%31.83M

346.07%60.22M

Net PPE purchase and sale

-101.32%-1.2M

-18.92%-44K

-93.94%-256K

-100.53%-499K

84.68%-399K

956.07%90.57M

98.50%-37K

96.58%-132K

4,629.16%93.35M

-18.57%-2.61M

Net investment purchase and sale

11.28%125.06M

-80.51%9.99M

18.18%70.7M

181.24%49.98M

-108.93%-5.61M

242.24%112.38M

334.49%51.26M

1,084.73%59.83M

-281.21%-61.52M

300.23%62.82M

Cash from discontinued investing activities

Investing cash flow

-38.97%123.87M

-80.58%9.94M

18.01%70.45M

55.48%49.48M

-109.98%-6.01M

811.83%202.96M

310.57%51.22M

4,899.75%59.7M

-0.20%31.83M

346.07%60.22M

Financing cash flow

Cash flow from continuing financing activities

-96.21%2.01M

-95.32%1.51M

2.80%-208K

-59.29%471K

-98.82%235K

-48.93%53.08M

-37.26%32.29M

-100.45%-214K

-52.72%1.16M

586.41%19.85M

Net issuance payments of debt

-82.82%-947K

-76.23%-215K

-0.97%-208K

-68.25%-212K

-387.50%-312K

-103.94%-518K

-96.77%-122K

-232.26%-206K

-96.88%-126K

3.03%-64K

Net common stock issuance

-90.24%2.14M

12.44%1.55M

--0

-117.39%-50K

-96.88%640K

-77.82%21.89M

-97.25%1.38M

--0

69.33%-23K

735.94%20.54M

Proceeds from stock option exercised by employees

-51.69%928K

-61.41%181K

--0

-42.93%747K

--0

-71.59%1.92M

-70.17%469K

-94.42%47K

-49.63%1.31M

-94.51%96K

Net other financing activities

-100.36%-107K

--0

-366.67%-14K

87.08%-93K

2,462.41%29.79M

--30.57M

---55K

76.92%-3K

42.31%-720K

Cash from discontinued financing activities

Financing cash flow

-96.21%2.01M

-95.32%1.51M

2.80%-208K

-59.29%471K

-98.82%235K

-48.93%53.08M

-37.26%32.29M

-100.45%-214K

-52.72%1.16M

586.41%19.85M

Net cash flow

Beginning cash position

-13.39%93.09M

-2.29%64.94M

-36.08%46.04M

-52.54%48.89M

-13.39%93.09M

-46.74%107.48M

-42.01%66.46M

-42.49%72.03M

-32.45%103.02M

-46.74%107.48M

Current changes in cash

-366.30%-67.1M

-246.27%-38.95M

438.95%18.89M

90.82%-2.84M

-890.39%-44.2M

84.74%-14.39M

473.73%26.63M

47.65%-5.57M

-13.73%-30.98M

90.95%-4.46M

End cash Position

-72.08%25.99M

-2.29%64.94M

-36.08%46.04M

-52.54%48.89M

-13.39%93.09M

-42.01%66.46M

-42.49%72.03M

-32.45%103.02M

Free cash flow

29.28%-194.2M

11.36%-50.45M

20.80%-51.63M

18.49%-53.3M

55.44%-38.83M

-18.83%-274.62M

-54.94%-56.92M

-3.75%-65.19M

-2.74%-65.38M

-28.34%-87.13M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	28.64%-192.98M	11.38%-50.41M	21.08%-51.35M	17.46%-52.8M	54.54%-38.43M	-22.63%-270.43M	-65.98%-56.88M	-10.31%-65.06M	-3.88%-63.96M	-28.66%-84.53M
Net income from continuing operations	-20.95%-276.13M	18.94%-60.45M	17.00%-69.8M	-485.08%-71.11M	15.13%-74.77M	32.88%-228.3M	20.11%-74.57M	0.68%-84.09M	122.04%18.47M	-12.47%-88.11M
Operating gains losses	----	----	----	----	----	---50.24M	--0	--0	----	----
Depreciation and amortization	-14.58%4.83M	-3.98%1.21M	-11.69%1.21M	-16.48%1.2M	-23.70%1.21M	-39.51%5.65M	-49.56%1.26M	-40.91%1.37M	-37.96%1.44M	-28.40%1.59M
Other non cash items	85.40%16.8M	41.12%4.08M	56.60%4.34M	52.51%4.22M	556.62%4.16M	340.76%9.06M	302.93%2.89M	412.38%2.77M	584.90%2.77M	60.91%634K
Change In working capital	124.96%15.34M	-440.84%-7.28M	178.93%1.97M	102.15%1.09M	245.02%19.55M	-216.89%-61.47M	-94.83%2.14M	-91.84%707K	-1,078.21%-50.83M	-417.15%-13.48M
-Change in receivables	115.58%6.11M	15.08%-33.95M	-11.34%344K	-454.84%-110K	12,423.27%39.82M	-14,961.74%-39.24M	-3,953.96%-39.97M	--388K	-99.68%31K	103.80%318K
-Change in inventory	-411.98%-8.12M	-96.41%-3.12M	--1.27M	---2.52M	---3.75M	---1.59M	---1.59M	--0	--0	--0
-Change in prepaid assets	----	----	----	227.75%2.75M	-524.30%-2.58M	----	----	----	-464.64%-2.16M	-66.68%609K
-Change in payables and accrued expense	-391.55%-6.79M	-303.89%-5.45M	5.83%10.8M	-38.99%-9.03M	23.14%-3.11M	-65.25%2.33M	-30.28%2.67M	600.07%10.2M	-117.70%-6.49M	-192.09%-4.05M
-Change in other current assets	-16.18%1.32M	-90.82%515K	122.12%911K	84.00%46K	-405.88%-156K	-75.68%1.57M	-12.69%5.61M	-45,855.56%-4.12M	225.00%25K	34.21%51K
-Change in other current liabilities	74.41%-1.43M	267.33%7.77M	-2,632.20%-5.98M	2,816.39%1.66M	-337.33%-4.89M	-645.07%-5.59M	-206.46%-4.65M	-28.70%236K	90.88%-61K	-201.18%-1.12M
-Change in other working capital	227.93%24.26M	-32.73%26.94M	31.04%-5.2M	119.67%8.3M	37.80%-5.78M	-147.50%-18.96M	-9.81%40.05M	-385.83%-7.55M	-3,063.84%-42.17M	-475.84%-9.29M
Cash from discontinued investing activities
Operating cash flow	28.64%-192.98M	11.38%-50.41M	21.08%-51.35M	17.46%-52.8M	54.54%-38.43M	-22.63%-270.43M	-65.98%-56.88M	-10.31%-65.06M	-3.88%-63.96M	-28.66%-84.53M
Investing cash flow
Cash flow from continuing investing activities	-38.97%123.87M	-80.58%9.94M	18.01%70.45M	55.48%49.48M	-109.98%-6.01M	811.83%202.96M	310.57%51.22M	4,899.75%59.7M	-0.20%31.83M	346.07%60.22M
Net PPE purchase and sale	-101.32%-1.2M	-18.92%-44K	-93.94%-256K	-100.53%-499K	84.68%-399K	956.07%90.57M	98.50%-37K	96.58%-132K	4,629.16%93.35M	-18.57%-2.61M
Net investment purchase and sale	11.28%125.06M	-80.51%9.99M	18.18%70.7M	181.24%49.98M	-108.93%-5.61M	242.24%112.38M	334.49%51.26M	1,084.73%59.83M	-281.21%-61.52M	300.23%62.82M
Cash from discontinued investing activities
Investing cash flow	-38.97%123.87M	-80.58%9.94M	18.01%70.45M	55.48%49.48M	-109.98%-6.01M	811.83%202.96M	310.57%51.22M	4,899.75%59.7M	-0.20%31.83M	346.07%60.22M
Financing cash flow
Cash flow from continuing financing activities	-96.21%2.01M	-95.32%1.51M	2.80%-208K	-59.29%471K	-98.82%235K	-48.93%53.08M	-37.26%32.29M	-100.45%-214K	-52.72%1.16M	586.41%19.85M
Net issuance payments of debt	-82.82%-947K	-76.23%-215K	-0.97%-208K	-68.25%-212K	-387.50%-312K	-103.94%-518K	-96.77%-122K	-232.26%-206K	-96.88%-126K	3.03%-64K
Net common stock issuance	-90.24%2.14M	12.44%1.55M	--0	-117.39%-50K	-96.88%640K	-77.82%21.89M	-97.25%1.38M	--0	69.33%-23K	735.94%20.54M
Proceeds from stock option exercised by employees	-51.69%928K	-61.41%181K	--0	-42.93%747K	--0	-71.59%1.92M	-70.17%469K	-94.42%47K	-49.63%1.31M	-94.51%96K
Net other financing activities	-100.36%-107K	--0	--0	-366.67%-14K	87.08%-93K	2,462.41%29.79M	--30.57M	---55K	76.92%-3K	42.31%-720K
Cash from discontinued financing activities
Financing cash flow	-96.21%2.01M	-95.32%1.51M	2.80%-208K	-59.29%471K	-98.82%235K	-48.93%53.08M	-37.26%32.29M	-100.45%-214K	-52.72%1.16M	586.41%19.85M
Net cash flow
Beginning cash position	-13.39%93.09M	-2.29%64.94M	-36.08%46.04M	-52.54%48.89M	-13.39%93.09M	-46.74%107.48M	-42.01%66.46M	-42.49%72.03M	-32.45%103.02M	-46.74%107.48M
Current changes in cash	-366.30%-67.1M	-246.27%-38.95M	438.95%18.89M	90.82%-2.84M	-890.39%-44.2M	84.74%-14.39M	473.73%26.63M	47.65%-5.57M	-13.73%-30.98M	90.95%-4.46M
End cash Position	-72.08%25.99M	-72.08%25.99M	-2.29%64.94M	-36.08%46.04M	-52.54%48.89M	-13.39%93.09M	-13.39%93.09M	-42.01%66.46M	-42.49%72.03M	-32.45%103.02M
Free cash flow	29.28%-194.2M	11.36%-50.45M	20.80%-51.63M	18.49%-53.3M	55.44%-38.83M	-18.83%-274.62M	-54.94%-56.92M	-3.75%-65.19M	-2.74%-65.38M	-28.34%-87.13M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall